Main Sequence is an Australian deep tech investment fund that helps turn scientific research into new companies and industries. Established to manage the CSIRO Innovation Fund, the firm partners with scientists, researchers, and industry collaborators to identify promising technologies, provide funding, and support their development into ventures with practical impact. Its investment activity spans areas including healthcare, food production, and other sectors shaped by advanced science and technology.
Advise Main Sequence on venture capital investments, portfolio company matters and fund compliance. Partner with the General Counsel to develop AI-enabled legal workflows.